Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells - Wikidata - wikimedia - TriplyDB

Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells

Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells

http://www.wikidata.org/entity/Q35586803

about

Targeting RANKL in metastasis Activin upregulation by NF-κB is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer.IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance.Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells.Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells.NF-κB affects proliferation and invasiveness of breast cancer cells by regulating CD44 expression.Cytoplasmic Localization of Proline, Glutamic Acid, Leucine-rich Protein 1 (PELP1) Induces Breast Epithelial Cell Migration through Up-regulation of Inhibitor of κB Kinase ϵ and Inflammatory Cross-talk with Macrophages.Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells Identification of novel focal adhesion kinase substrates: role for FAK in NFκB signaling Balancing the innate immune system in tumor development.Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway Circadian disruption-induced microRNAome deregulation in rat mammary gland tissues.Increased chemokine receptor IL-17RA expression is associated with poor survival in gastric cancer patients.Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression.Non-Canonical EZH2 Transcriptionally Activates RelB in Triple Negative Breast Cancer Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cells Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions Overcoming adaptive resistance in mucoepidermoid carcinoma through inhibition of the IKK-β/IκBα/NFκB axis Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells Research progress in signalling pathway in diabetic nephropathy.Twist-BRD4 complex: potential drug target for basal-like breast cancer.Clinical significance of CYLD downregulation in breast cancer.Concise Review: An (Im)Penetrable Shield: How the Tumor Microenvironment Protects Cancer Stem Cells.Breast cancer stem cells as last soldiers eluding therapeutic burn: A hard nut to crack.Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer.HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling.Honey and Cancer: Current Status and Future Directions RNF20 and histone H2B ubiquitylation exert opposing effects in Basal-Like versus luminal breast cancer.Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers.Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth The ANK repeats of Notch-4/Int3 activate NF-κB canonical pathway in the absence of Rbpj and causes mammary tumorigenesis.NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH+ Cancer Stem-like Cells.Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment.Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells.Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells.FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin.IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts.DARPP-32 and t-DARPP promote non-small cell lung cancer growth through regulation of IKKα-dependent cell migration The "Yin and Yang" of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers

P2860

Q26849690-3607E9EA-66EB-4126-86AC-74E43F883143 Q30301260-CA93D175-800D-4F7F-AF5E-487BB51CC316 Q33276239-44F3ED4F-30C3-4C90-AE13-C380472DEDE1 Q33757061-01DB42E8-06AC-4978-B24E-664B485E231E Q33760216-85A7097F-FCEE-4516-8AD8-7594193AB36F Q33913799-88221DA2-97F7-42B0-B5B1-2728E06E78BC Q34129082-E5E84554-8D25-43E0-89BA-617BF894430D Q34545700-5318101A-78F7-408D-AA9D-F39E6C7B4084 Q34752692-3619A551-B41F-4C8B-BC61-350E55FA4001 Q35197497-61697ECC-1B7D-43AD-88BD-47D1BBB1890D Q35236394-DC44E308-6446-4BB6-AC3D-EF433AEAEB2E Q35740040-E0927B34-6FB3-409A-BCAB-6ED63BA22ECD Q35745008-7AF14A03-A157-4419-AF99-95E4C951060E Q35919243-B887C03E-18E5-4BAF-AB77-16D7A9EB54E3 Q36086628-A4BC1A8F-E123-473C-A41C-C50A6FC3ABD4 Q36169303-5E66CEDB-034F-428D-B2D8-CEE4770684CA Q36485168-995AFCFA-4DF1-45F3-BB4A-07E11C4A5626 Q36544675-478DCA85-CDE1-448A-B303-05BCC1E12213 Q37687338-E176ED80-BF46-41DC-BF6D-B65D0C82B6B2 Q37708924-7B357307-9DF8-4D24-9F27-D3B6854343EA Q38217707-2FDC98C4-E1AA-4490-9F50-4CAA46594BBE Q38288525-11DB6A73-7C34-41A4-B2B8-0DE025416CC6 Q39036670-DC7B3BB6-838F-402E-8A82-0151BC04E2EE Q39138664-DD15503C-2C88-4E7B-BB38-D8F481286C6E Q39443694-EF0C1418-CF5B-4BCA-8854-0B60EA82890A Q41470786-3B87BA99-1271-4F31-9B65-8DBE95DFC183 Q41708922-FFC95BDF-2666-48C5-A5C8-B7C3319B5855 Q41836861-A9A07EA3-B974-4DAF-B833-49107B6A779B Q42505152-0B7448CE-5E99-48D4-A3A2-896CFA4F41ED Q42505998-BD3B50CC-25E6-461E-9762-FB5CF301535C Q42645448-EBD37320-B249-4477-83F4-A5CED70CFBAB Q42652857-C6367613-45B7-404D-9E05-9E26E66C8E9D Q47598471-2C16E4DD-1C4B-4DBC-8150-F7315BA69516 Q47699487-49D73542-73CF-47A9-8919-B9250D3B0720 Q48832407-4A8F3EA7-330A-49B5-A995-0A70E58D4CEA Q48832449-DDC479B0-6298-4E56-867B-DB4538A0AE1F Q55096590-C91ECD0A-A938-48F4-9532-21B576D6ECFC Q55247109-D042AF09-5932-4993-B576-601FB676926B Q56815794-F7BBEF9F-B418-4839-BB7F-0D59A4E4CD24 Q58702607-C76FD371-D3D5-48D2-BAFB-426DF1C2568A

P2860

Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells

http://www.wikidata.org/entity/Q35586803

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells

@ast

Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells

@en

type

label

Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells

@ast

Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells

@en

prefLabel

Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells

@ast

Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells

@en

P1433

Q35586803-22A8332A-31A1-47BC-A70C-3ED7A69011F5

P1476

Q35586803-F3EFE870-AD55-45BA-8006-EEB175531407

P2093

Q35586803-305A19B4-352C-4B19-A6AC-9F4865C50538

Q35586803-435762B0-356C-40DC-8FE2-7EC7B74765ED

Q35586803-B10DF8C2-8149-469E-9FE2-1B1BCE8BE87D

Q35586803-F74D21BC-53CA-46C1-B96B-C17EDD4D33D9

Q35586803-F94F44C9-384C-41ED-AE4F-0F540111B42E

P2860

Q35586803-00BAE136-C3BB-4064-9E5E-61ACEBADC9D0

Q35586803-04D2852D-4930-4652-BF14-178EA6B27AF7

Q35586803-05B554D1-ABD5-4A13-8748-74DDA451083D

Q35586803-092A9BC3-D2EE-40B6-B1E2-F25E6225CA95

Q35586803-0B3D60AF-275B-45DD-BFB1-3AC0F8D82612

Q35586803-0CA38365-EA97-4D5C-A891-4E618CC4CE8A

Q35586803-0F7C08B9-1680-4A44-B89F-3E74CA7C9885

Q35586803-10F693F1-3C8D-4C3F-8265-8896FCE71DD5

Q35586803-129A4EF7-773F-4EAC-AA5F-3E36381BAD41

Q35586803-1CDC5D8D-9059-4851-848C-E127EEEA5CA2

P2888

Q35586803-7294A580-10D9-42C3-AA06-6E93265917AD

P304

Q35586803-9B51433C-8CFD-4969-92FB-6B2ADE6BD269

P31

Q35586803-ECC5FDCB-DADC-4F54-8F67-B8387BCBF7B6

P356

Q35586803-574B0B50-8531-4F54-9F3C-16A335C558B3

P407

Q35586803-65DE7465-6ECE-4746-92D0-D9E44F8AB14C

P433

Q35586803-0BCF4755-FF9A-4307-881C-7558B7F99869

P478

Q35586803-2C22AA5D-5732-4DCA-B048-1AE097C4FF21

P577

Q35586803-2C243795-238E-4C7A-B316-32E1782E53E3

P698

Q35586803-13254406-9924-4762-ABEC-D328ED676E45

P921

Q35586803-2DF0865B-18DC-4A46-A236-751D841840CF

P932

Q35586803-A2F99354-FE1B-4A57-AD72-EA45E3D7C6C8

P356

P1433

P1476

Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells

@en

P2093

A S Baldwin

http://www.w3.org/2001/XMLSchema#string

C L Lawrence

http://www.w3.org/2001/XMLSchema#string

J W Bradford

http://www.w3.org/2001/XMLSchema#string

K S Clark

http://www.w3.org/2001/XMLSchema#string

M F Kendellen

http://www.w3.org/2001/XMLSchema#string

P2860

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

TAK1 is a ubiquitin-dependent kinase of MKK and IKK

Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling

Eyes wide open: a critical review of sphere-formation as an assay for stem cells

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation

The epithelial-mesenchymal transition generates cells with properties of stem cells

The basics of epithelial-mesenchymal transition

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Prospective identification of tumorigenic breast cancer cells

P2888

P304

1297-1305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2013.64

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23474754

http://www.w3.org/2001/XMLSchema#string

P921

P932

4425414

http://www.w3.org/2001/XMLSchema#string